SG Americas Securities, LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 145 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,099
-2.6%
165,016
+7.9%
0.02%
+50.0%
Q2 2023$2,154
+734.9%
152,974
+815.1%
0.02%
+433.3%
Q1 2023$258
+65.4%
16,717
+75.6%
0.00%
+50.0%
Q4 2022$156
-100.0%
9,520
-54.3%
0.00%
-60.0%
Q3 2022$385,000
-29.6%
20,836
-49.9%
0.01%
-16.7%
Q2 2022$547,000
+88.0%
41,583
+386.2%
0.01%
+500.0%
Q3 2021$291,000
-18.5%
8,552
-12.4%
0.00%
-50.0%
Q2 2021$357,000
-44.3%
9,759
-31.8%
0.00%
-33.3%
Q1 2021$641,000
+181.1%
14,299
+257.7%
0.00%
+200.0%
Q4 2020$228,000
-91.2%
3,998
-92.1%
0.00%
-93.8%
Q3 2020$2,584,000
+1420.0%
50,368
+1668.5%
0.02%
+1500.0%
Q2 2020$170,000
-5.6%
2,848
-34.7%
0.00%
-50.0%
Q1 2020$180,000
-2.7%
4,360
+46.6%
0.00%0.0%
Q4 2019$185,000
-44.6%
2,975
-65.0%
0.00%
-33.3%
Q2 2018$334,000
+119.7%
8,495
+12.1%
0.00%
+200.0%
Q1 2018$152,000
+6.3%
7,576
+0.4%
0.00%0.0%
Q3 2017$143,0007,5440.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders